[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioMedWire "$MRK Foundation co-hosts the 12th Africa Asia Luminary in Banjul The Gambia with First Lady Fatoumatta Bah-Barrow. Over 6000 global leaders unite for healthcare and women's empowerment: #MerckFoundation #AfricaAsiaLuminary #HealthcareLeadership"
X Link @BioMedWire 2025-10-15T14:00Z 1299 followers, XX engagements

"$MRK showcases new data on HIV treatment and prevention at EACS 2025 featuring DOR/ISL and MK-8591D trials. Advancing the fight against HIV with innovative therapies: #Merck #EACS2025 #HIVResearch #InnovativeTherapies #DORISL #MK8591D"
X Link @BioMedWire 2025-10-13T14:00Z 1298 followers, XXX engagements

"$SNGX Closes Multimillion-Dollar Public Offering to Fund Pipeline Through 2026"
X Link @BioMedWire 2025-10-13T19:30Z 1297 followers, XX engagements

"$AZN baxdrostat showed substantial blood pressure reduction in treatment-resistant hypertensionpotential new option for patients whose BP remains uncontrolled: #Hypertension #BloodPressure #CardioResearch #PharmaInnovation"
X Link @BioMedWire 2025-10-07T18:00Z 1299 followers, XX engagements

"$MRK Keytruda Qlex secures FDA approval for subcutaneous use in XX solid tumor indications enhancing patient convenience and extending patent protection: #Merck #KeytrudaQlex #FDAApproval #CancerTreatment #OncologyInnovation #MRKStock"
X Link @BioMedWire 2025-10-14T14:00Z 1299 followers, XX engagements

"InvestorNewsBreaks $BEAT Combining Portability and Precision to Redefine Future of Cardiac Care"
X Link @BioMedWire 2025-10-16T17:44Z 1298 followers, X engagements

"$MRK reports win from its Phase X HYPERION trial: WINREVAIR cut risk of clinical worsening by XX% benefit evident within X weeks: #Pharma #ClinicalTrials #PAH #Winrevair #Merck"
X Link @BioMedWire 2025-10-02T15:00Z 1297 followers, XX engagements

"$AZN partners with Turbine to advance ADC discovery through AI-driven virtual disease models aiming to predict treatment responses and streamline drug development processes: #AstraZeneca #Turbine #ADCs #CancerResearch #AIinPharma #DrugDiscovery"
X Link @BioMedWire 2025-10-09T18:00Z 1299 followers, XX engagements

"$AZN $4.5B Albemarle plant enhances UVAs biotech ecosystem fostering research and job growth. A win for innovation and collaboration in Central Virginia: #AstraZeneca #UVA #Biotech #Innovation #LifeSciences #Virginia"
X Link @BioMedWire 2025-10-10T14:01Z 1299 followers, XX engagements

"$AZN Young Health Programme empowers India's youth to combat NCDs through peer education community engagement and skill-building. By addressing risk factors early it fosters healthier futures: #AstraZeneca #YouthHealth #NCDPrevention #India"
X Link @BioMedWire 2025-10-13T18:00Z 1299 followers, XX engagements

"$AZN strikes a deal with Trump agreeing to offer discounts to Medicaid in return for tariff relief: #DrugPrices #Medicaid #HealthPolicy #AstraZenecaDeal"
X Link @BioMedWire 2025-10-12T18:00Z 1299 followers, XXX engagements

"$AZN Pharma India has shifted its technical trend from mildly bullish to bullish reflecting strong performance and positive momentum: #AstraZeneca #PharmaIndia #StockMarket #TechnicalAnalysis #BullishTrend #Investing"
X Link @BioMedWire 2025-10-15T18:00Z 1299 followers, XX engagements

"MissionIRNewsBreaks $BEAT on the Beat of Cardiac Innovation"
X Link @BioMedWire 2025-10-08T19:32Z 1297 followers, XX engagements

"$MRK KGaA revises healthcare growth outlook to low-mid single digits; 2025 sales forecast now 20.521.7B. CEO Garijo signals continued M&A focus: #Merck #Healthcare #LifeSciences #BusinessUpdate #MergersAndAcquisitions"
X Link @BioMedWire 2025-10-16T14:00Z 1298 followers, XXX engagements

"$AZN Pharma India introduces Lokelma to manage hyperkalaemia in adults. Available from November 2025: #AstraZeneca #Lokelma #Hyperkalaemia #IndiaHealthcare #PharmaNews"
X Link @BioMedWire 2025-10-16T18:00Z 1299 followers, XX engagements

"$AZN showcases pivotal trial data at ESMO 2025 focusing on breast bladder and gastric cancers. Collaborations with Daiichi Sankyo Merck & Co. and HUTCHMED enhance their oncology portfolio: #AstraZeneca #ESMO2025 #CancerCare #OncologyResearch"
X Link @BioMedWire 2025-10-14T18:00Z 1299 followers, XXX engagements

"$MRK KGaA integrates Quris Bio-AI platform to enhance drug safety predictions and reduce animal testing. This collaboration aims to streamline clinical trial readiness by assessing preclinical candidates' liver toxicity risks: #PharmaInnovation #Merck"
X Link @BioMedWire 2025-09-30T14:00Z 1299 followers, 2833 engagements

"BioMedNewsBreaks $SNGX Updates U.S. Medical Advisory Board to Advance Phase X Development of HyBryte for CTCL"
X Link @BioMedWire 2025-10-14T18:45Z 1299 followers, XX engagements